DossierENTITY

clinical development capabilities

Coverage of clinical development capabilities in the Nexus archive.

Earliest in view: Jul 21 · 10:45 UTCMost recent: Jul 21 · 10:45 UTC

Co-mentioned in this coverage

Recent coverage

BUSINESSJul 21 · 10:45 UTCBLOOMBERG
US-Based Axiom Seeks Hong Kong IPO to Tap China’s Biotech Boom
Axiom Biosciences is considering a Hong Kong initial public offering, a rare move for an American biotechnology firm. The IPO aims to leverage China's growing clinical development capabilities in the biotech sector.